Patient Preferences for Screening Barrett's Esophagus and Esophageal Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand patients' perspectives on screening tests for esophageal cancer and Barrett's esophagus, a condition that can lead to this cancer. Insights gained will help improve screening practices to reduce esophageal cancer deaths in the United States. Participants will complete a survey about their screening preferences. Ideal candidates have three or more risk factors, such as chronic heartburn (GERD), being male, smoking, obesity, or a family history of these conditions.
As an unphased trial, this study offers participants the chance to contribute to important research that could enhance future screening methods.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
Why are researchers excited about this trial?
Researchers are excited about this trial because it focuses on understanding patient preferences for screening tests related to Barrett's Esophagus and esophageal cancer. Unlike traditional methods that primarily emphasize medical efficacy, this trial aims to gather insights into what patients value most in their screening options. By using a discrete choice-based conjoint survey, researchers hope to tailor future screening approaches to align more closely with patient desires, potentially enhancing participation rates and early detection. This patient-centric approach could lead to more personalized care and improved health outcomes.
Who Is on the Research Team?
Jennifer Kolb, MD, MS
Principal Investigator
University of California, Los Angeles
Sachin Wani, MD
Principal Investigator
University of Colorado, Denver
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Survey
Participants complete a discrete choice-based conjoint survey to evaluate preferences for BE/EAC screening tests
Follow-up
Participants are monitored for any changes in preferences or additional feedback after survey completion
What Are the Treatments Tested in This Trial?
Interventions
- Patient Preferences Survey
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
556 eligible patients will be recruited across 5 participating sites to complete a discrete choice-based conjoint survey. The survey will be distributed to eligible patients via Sawtooth internet survey at the time of a clinic appointment or remotely via video chat.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor
University of Michigan
Collaborator
Exact Sciences Corporation
Industry Sponsor
University of California, Los Angeles
Collaborator
University of Texas Southwestern Medical Center
Collaborator
American Society for Gastrointestinal Endoscopy
Collaborator
VA Medical Center-West Los Angeles
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.